Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.

Dechend R, Gieffers J, Dietz R, Joerres A, Rupp J, Luft FC, Maass M.

Circulation. 2003 Jul 22;108(3):261-5. Epub 2003 Jul 14.

PMID:
12860900
2.

HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.

Viedt C, Shen W, Fei J, Kamimura M, Hänsch GM, Katus HA, Kreuzer J.

Basic Res Cardiol. 2003 Nov;98(6):353-61. Epub 2003 Sep 22.

PMID:
14556080
3.
4.

Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae.

Kothe H, Dalhoff K, Rupp J, Müller A, Kreuzer J, Maass M, Katus HA.

Circulation. 2000 Apr 18;101(15):1760-3.

PMID:
10769273
5.

Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.

Li J, Li JJ, He JG, Nan JL, Guo YL, Xiong CM.

Cardiovasc Ther. 2010 Spring;28(1):8-14. doi: 10.1111/j.1755-5922.2009.00103.x.

PMID:
20074254
6.

HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.

Narumiya H, Sasaki S, Kuwahara N, Irie H, Kusaba T, Kameyama H, Tamagaki K, Hatta T, Takeda K, Matsubara H.

Cardiovasc Res. 2004 Nov 1;64(2):331-6.

PMID:
15485693
7.

HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.

Cirillo P, Pacileo M, De Rosa S, Calabrò P, Gargiulo A, Angri V, Prevete N, Fiorentino I, Ucci G, Sasso L, Petrillo G, Musto D'Amore S, Chiariello M.

J Vasc Res. 2007;44(6):460-70. Epub 2007 Jul 26.

PMID:
17657162
8.

Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.

Li M, Liu Y, Dutt P, Fanburg BL, Toksoz D.

Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L463-71. Epub 2007 Jun 1.

9.

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.

Blanco-Colio LM, Muñoz-García B, Martín-Ventura JL, Lorz C, Díaz C, Hernández G, Egido J.

Circulation. 2003 Sep 23;108(12):1506-13. Epub 2003 Sep 2.

PMID:
12952848
10.

Impact of HMG CoA reductase inhibition on small GTPases in the heart.

Laufs U, Kilter H, Konkol C, Wassmann S, Böhm M, Nickenig G.

Cardiovasc Res. 2002 Mar;53(4):911-20.

PMID:
11922901
11.

Cellular antioxidant effects of atorvastatin in vitro and in vivo.

Wassmann S, Laufs U, Müller K, Konkol C, Ahlbory K, Bäumer AT, Linz W, Böhm M, Nickenig G.

Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):300-5.

PMID:
11834532
12.

3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.

Guijarro C, Blanco-Colio LM, Ortego M, Alonso C, Ortiz A, Plaza JJ, Díaz C, Hernández G, Egido J.

Circ Res. 1998 Sep 7;83(5):490-500.

PMID:
9734471
13.

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.

Mulhaupt F, Matter CM, Kwak BR, Pelli G, Veillard NR, Burger F, Graber P, Lüscher TF, Mach F.

Cardiovasc Res. 2003 Sep 1;59(3):755-66.

PMID:
14499877
14.

3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.

Wagner AH, Gebauer M, Güldenzoph B, Hecker M.

Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1784-9.

PMID:
12426205
15.

Lipophilic statins induce apoptosis of human vascular smooth muscle cells.

Guijarro C, Blanco-Colio LM, Massy ZA, O'Donnell MP, Kasiske BL, Keane WF, Egido J.

Kidney Int Suppl. 1999 Jul;71:S88-91.

PMID:
10412746
16.

Statins have biphasic effects on angiogenesis.

Weis M, Heeschen C, Glassford AJ, Cooke JP.

Circulation. 2002 Feb 12;105(6):739-45.

PMID:
11839631
17.

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.

Schönbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U, Robbie L, Ganz P, Kinlay S, Libby P.

Circulation. 2002 Dec 3;106(23):2888-93.

PMID:
12460867
18.
19.

Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway.

Nakata S, Tsutsui M, Shimokawa H, Yamashita T, Tanimoto A, Tasaki H, Ozumi K, Sabanai K, Morishita T, Suda O, Hirano H, Sasaguri Y, Nakashima Y, Yanagihara N.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):92-8. Epub 2006 Nov 2.

PMID:
17082483
20.

Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.

Kizu A, Shioi A, Jono S, Koyama H, Okuno Y, Nishizawa Y.

J Cell Biochem. 2004 Nov 15;93(5):1011-9.

PMID:
15389884

Supplemental Content

Support Center